Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Exploratory Efficacy of PSC-01, an Autologous Adipose-derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis

NCT04043819 is registered in ClinicalTrials.gov with Personalized Stem Cells, Inc. as lead sponsor.

NCT NCT04043819
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04043819 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Exploratory Efficacy of PSC-01, an Autologous Adipose-derived Stromal Vascular Fraction Cell Therapy Product for the Treatment of Knee Osteoarthritis
Lead sponsor
Personalized Stem Cells, Inc.
Phase
Phase 1
Overall status
Unknown status
Start date
September 7, 2019
Completion date
January 31, 2021
Enrollment
125 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis